Abstract:Identifying the alert groups of mechanism-based inactivators of human cytochrome P450s (hCYPs) is very helpful for early prediction of drug toxicity and for rational drug design to avoid idiosyncratic toxicity. Here, we report that a natural compound bufalin (BF) could time-dependently inactivate hCYP3A via complex CYP-catalyzed cascade oxidative metabolism. Metabolite profiling and time-dependent inhibition assays showed that 3-keto-bufalin (3-KBF), a unique nonpolar oxidative metabolite of BF, was the key substance responsible for hCYP3A inactivation. Further investigations demonstrated that 3-KBF was further metabolized by hCYPs to generate two mono-hydroxylated metabolites, which could be readily dehydrated and then covalently bound on glutathione or hCYP3A4. Collectively, this study uncovers unique CYP-catalyzed cascade oxidative pathways of BF in which two reactive intermediates bearing a Michael acceptor are finally formed as hCYP3A inactivators. These findings expand the current knowledge of CYP inactivators and suggest that some steroids bearing the 3-keto group may trigger time-dependent CYP3A inactivation.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01875.Inhibitory effects of compounds from Chinese medicine on hCYP3A; analytical conditions for quantification of the internal standard and the metabolite of midazolam; inhibitory effects of BF, 5-HBF, and 3-KBF; chemical structures of BF and its oxidative metabolites; effects of various trapping or protecting agents on the inactivation of hCYP3A by 3-KBF; time-dependent inhibition kinetics of BF and 3-KBF in rhCYP3A4; determination of the partition ratio for hCYP3A4 inactivation; mass spectra of product ions of 3-KBF; formation of the oxidative metabolites of 3-KBF in recombinant P450 enzymes; mass spectrometric characterization of the Michael receptor; MS/MS spectrum for the modified peptide from hCYP3A4; possible covalent binding poses of the reactive metabolites of 3-KBF; 2D representation of the key interactions; mass spectrometric characterization of the GSH adducts; HPLC-UV profiles of BF and 3-KBF; C-NMR and H-NMR spectra of 3-KBF, 3-KRB, and 3-KCB (PDF)This article has not yet been cited by other publications.

A highly selective probe for human cytochrome P450 3A4: isoform selectivity, kinetic characterization and its applications.

An activity-based fluorogenic probe for sensitive and selective monoamine oxidase-B detection.

A dual functional probe for assessing human CYP450 3A5 and 3A enzymes bioactivities

Investigation on Modulation of Human Cytochrome P450 and P-glycoprotein by Herb or Natural Product Using in Vivo Probe Substrate

Fluorescent probes for the detection and imaging of Cytochrome P450

A practical strategy to develop isoform-selective near-infrared fluorescent probes for human cytochrome P450 enzymes

Expression and Characterization of Human Cytochrome P450 1A2

Discovery of Novel N,N-3-phenyl-3-benzylaminopropionanilides As Potent Inhibitors of Cholesteryl Ester Transfer Protein in Vivo.

Rational Molecular Design of a Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2D6

Absolute Quantification of Cytochrome P450 and Uridinediphosphate Glucuronosyl Transferase Isoforms by Proteomics-based Approach

Sensing cytochrome P450 1A1 activity by a resorufin-based isoform-specific fluorescent probe

Study Heterogenous Expression and Activity Determination of Human Cytochrome P450 2B6

Rationally Engineered CYP3A4 Fluorogenic Substrates for Functional Imaging Analysis and Drug-Drug Interaction Studies

Rational Design of a Highly Selective Ugt1a1 Probe and Its Application in Drug Discovery

Collaborative Modification Strategy to Develop a Highly Selective Fluorescent Probe for Human UDP-glucuronosyltransferase 1A10

Drugs As CYP3A Probes, Inducers, and Inhibitors

Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail in vitro with emphasis on CYP2E1

Characterization of CYP3A5 Selective Inhibitors for Reaction Phenotyping of Drug Candidates

[Heterogeneous expression of human CYP and its application in early stage of new drug research and development].

Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A

The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes